Your browser doesn't support javascript.
loading
The coronary risk of cyclo-oxygenase-2 inhibitors in patients with a previous myocardial infarction.
Brophy, J M; Lévesque, L E; Zhang, B.
Affiliation
  • Brophy JM; Department of Epidemiology and Biostatistics, McGill University Health Centre, McGill University, Montréal, Québec, Canada. james.brophy@mcgill.ca
Heart ; 93(2): 189-94, 2007 Feb.
Article in En | MEDLINE | ID: mdl-16849374
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazoles / Sulfonamides / Sulfones / Cyclooxygenase 2 Inhibitors / Lactones / Myocardial Infarction Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male Language: En Journal: Heart Journal subject: CARDIOLOGIA Year: 2007 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazoles / Sulfonamides / Sulfones / Cyclooxygenase 2 Inhibitors / Lactones / Myocardial Infarction Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male Language: En Journal: Heart Journal subject: CARDIOLOGIA Year: 2007 Document type: Article Affiliation country: Country of publication: